Medical Science Director at Mitsubishi Tanabe Pharma America. #ALS EPTX➡️HTX. Salsa dancer💃🏻. Views my own.
Houston, TX
Joined July 2017
- Tweets605
- Following1.3K
- Followers1.1K
- Likes1.6K
Pinned Tweet
Big news! I have accepted a position @MTPA_US as a Medical Science Director focusing on their ALS and PD pipeline. With one of only two FDA-approved interventional drugs for ALS, MTPA is truly committed to improving patient lives and I’m thrilled to be joining an amazing team! – at Houston, TX
After 12 years in Houston, it’s time to go. The derecho and Beryl show our city’s unpreparedness. The lack of transparency on power restoration during a heat advisory proves nothing is being done to weatherize infrastructure. Shame on you @CenterPoint @GregAbbott_TX @DanPatrick
My tweet was quoted in this Newsweek article! newsweek.com/greg-abbott-fee…
Excited to be attending the @alsagoldenwest 13th Annual California ALS Research Summit and Champions for Cures and Care gala Jan. 20-21, 2023 in San Francisco. If attending, let me know, would love to meet you!
Dr. Jennifer Johnson retweeted
An oral formulation of edaravone, Radicava Oral suspension, has been approved in Canada for treating amyotrophic lateral sclerosis. buff.ly/3A4E2nq
#ALS #ALSNewsToday #amyotrophiclateralsclerosis #livingwithALS
Real-World Data Analysis of Survival with RADICAVA
Press release: mt-pharma-america.com/2022/0…
Dr. Jennifer Johnson retweeted
Post-hoc analysis showed slower progression in ALS patients on Radicava (edaravone), including those low FVC values; early start supported. buff.ly/3vmnOnt
#ALS #ALSNewsToday #amyotrophiclateralsclerosis #livingwithALS #ALScommunity #ALSadvocacy
This is a game-changer. Congrats to the team @MTPA_US and importantly, thank you to all the people with ALS who participated in the trials. Without them, this would not have been possible! There is still work to do- until we have a cure, we won’t stop.
Today we approved an oral treatment for adults with ALS, commonly referred to as Lou Gehrig’s disease.
ALS is a rare disease that attacks and kills the nerve cells that control voluntary muscles.
Learn more about this approval: fda.gov/drugs/news-events-hu…
Dr. Jennifer Johnson retweeted
We’re pleased to announce an important update on our development program. Read more here:
I am thrilled to be hosting @MichelleJoLo1 tomorrow at our BCM Neuroscience department seminar! More work is needed to foster an inclusive environment in research but we wouldn't be where we are today without Dr. Jones-London. Let's bring diverse and creative minds to the table!
We have another great seminar planned tomorrow (9/24) at 11am CT and all are welcome! Very excited to hear from @NINDSDiversity Chief, Dr. Michelle Jones-London, who will discuss strategies for enhancing the #diversity of #neuroscience researchers! bcm.edu/departments/neurosci…
Symptoms started at age 39 in first reported case of APP triplication! – at Houston, TX
Happy to share our report on 1st case of APP gene triplication (4 copies of APP) in a patient with early-onset cerebral amyloid angiopathy and Alzheimer disease with an age of onset among the earliest as compared to APP duplication carriers (3 copies)
ng.neurology.org/content/7/5…
Check out this beautiful review on the heterogeneity of different tauopathies that my dear friend and colleague @dchloechung contributed to! A lot of work and love went into this! Congrats to all authors! – at Houston, TX
'Cellular and pathological heterogeneity of primary #tauopathies'
@dchloechung @bcmhouston Shanu Roemer, Leonard Petrucelli @dennis_w_d
@MayoClinicNeuro
#tau #neuropathology
molecularneurodegeneration.b…
Had the privilege today of meeting Mike Loya, former head of Vitol and a generous donor to the NRI supporting our neurodegeneration research. Not only is he from El Paso, TX, he is a former Burges High School Mustang like me! Always inspired by El Pasoan success stories! ❤️
Dr. Jennifer Johnson retweeted
Really excited to share our manuscript "Rare variant contribution to human disease in 281,104 UK
2 Biobank exomes" now published in @Nature
nature.com/articles/s41586-0…
@AstraZeneca @kerencarss @DrAndrewHarper @ruth_march @SlavePetrovski @uk_biobank
Dr. Jennifer Johnson retweeted
Check out my new @brainpostco article to learn about progress in gene therapy research for brain diseases! 👇 #neuroscience #scicomm
Can Gene Therapy Help Treat Brain Diseases?
@brainpostco's scientific summary by @dchloechung:
brainpost.co/weekly-brainpos…
Wonderful review published in @AnnualReviews by @Gabriel_E_VV and Huda about Parkinson’s disease genetics and pathophysiology- check it out! – at Houston, TX
I am happy to share our review of Parkinson’s disease genetics and pathophysiology now online in @AnnualReviews. I hope it serves as an useful primer of the current state of the field and a launching point new inquiries!
annualreviews.org/doi/abs/10…
